{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:13:48Z","timestamp":1778836428922,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2021B1212040017"],"award-info":[{"award-number":["2021B1212040017"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271786"],"award-info":[{"award-number":["82271786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472267"],"award-info":[{"award-number":["82472267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"publisher","award":["ZDSYS20230626091203007"],"award-info":[{"award-number":["ZDSYS20230626091203007"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["SZSM202103008"],"award-info":[{"award-number":["SZSM202103008"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2025ZD01904500"],"award-info":[{"award-number":["2025ZD01904500"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2025ZD01904501"],"award-info":[{"award-number":["2025ZD01904501"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018536","name":"National Mega Project on Major Infectious Disease Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018536","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.virs.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:26:42Z","timestamp":1769214402000},"page":"196-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systematic evaluation of HSV-1 \u039434.5\u039447 as a dual-function platform for attenuated HSV-1 vaccine and heterologous antigen delivery"],"prefix":"10.1016","volume":"41","author":[{"given":"Ziyu","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haohang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingting","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2000-7053","authenticated-orcid":false,"given":"Caijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2026.01.002_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006141","article-title":"An HSV-2 trivalent vaccine is immunogenic in rhesus macaques and highly efficacious in Guinea pigs","volume":"13","author":"Awasthi","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.01.002_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.959603","article-title":"Monoclonal antibody therapy of herpes simplex virus: an opportunity to decrease congenital and perinatal infections","volume":"13","author":"Backes","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.01.002_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"Belshe","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virs.2026.01.002_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213401","article-title":"Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the Guinea pig model of genital herpes: reassessing efficacy using endpoints from clinical trials","volume":"14","author":"Bernstein","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.01.002_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/cid\/cis891","article-title":"Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women","volume":"56","author":"Bernstein","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virs.2026.01.002_bib6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.micinf.2005.03.003","article-title":"Early events in HSV keratitis--setting the stage for a blinding disease","volume":"7","author":"Biswas","year":"2005","journal-title":"Microb. Infect."},{"key":"10.1016\/j.virs.2026.01.002_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tim.2022.07.008","article-title":"T cell immunity in HSV-1- and VZV-infected neural ganglia","volume":"31","author":"Boeren","year":"2023","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virs.2026.01.002_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4049\/jimmunol.1200063","article-title":"CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis","volume":"189","author":"Conrady","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.virs.2026.01.002_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121062","article-title":"Shell-mediated phagocytosis to reshape viral-vectored vaccine-induced immunity","volume":"276","author":"Feng","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.virs.2026.01.002_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.virol.2012.10.006","article-title":"Varicella zoster vaccines and their implications for development of HSV vaccines","volume":"435","author":"Gershon","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virs.2026.01.002_bib11","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1093\/infdis\/jiaa573","article-title":"Live attenuated varicella vaccine: prevention of varicella and of zoster","volume":"224","author":"Gershon","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.01.002_bib12","doi-asserted-by":"crossref","first-page":"e01000","DOI":"10.1128\/JVI.01000-20","article-title":"Herpes simplex virus 1 (HSV-1) 0\u0394NLS live-attenuated vaccine protects against ocular HSV-1 infection in the absence of neutralizing antibody in HSV-1 gB T cell receptor-specific transgenic mice","volume":"94","author":"Gmyrek","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.01.002_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01724-21","article-title":"Noncognate signals drive enhanced effector CD8(+) T cell responses through an IFNAR1-Dependent pathway after infection with the prototypic vaccine, 0\u0394NLS, against Herpes simplex virus 1","volume":"96","author":"Gmyrek","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.01.002_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/infdis\/166.3.494","article-title":"Activation of human immunodeficiency virus by herpes simplex virus","volume":"166","author":"Golden","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.01.002_bib15","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(07)61908-4","article-title":"Genital herpes","volume":"370","author":"Gupta","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.01.002_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012251","article-title":"Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine","volume":"5","author":"Halford","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.virs.2026.01.002_bib17","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.vaccine.2015.12.076","article-title":"Status of vaccine research and development of vaccines for herpes simplex virus","volume":"34","author":"Johnston","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2026.01.002_bib18","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1038\/s41467-021-23036-9","article-title":"A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation","volume":"12","author":"Kang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.01.002_bib19","doi-asserted-by":"crossref","first-page":"24200","DOI":"10.1021\/acsnano.3c09521","article-title":"Rapid induction of long-lasting systemic and mucosal immunity via thermostable microneedle-mediated chitosan oligosaccharide-encapsulated DNA nanoparticles","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.virs.2026.01.002_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.gt.3301885","article-title":"ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties","volume":"10","author":"Liu","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.virs.2026.01.002_bib21","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0042-6822(92)90048-T","article-title":"Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes","volume":"186","author":"Margolis","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.virs.2026.01.002_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228252","article-title":"Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis","volume":"15","author":"Naidu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.01.002_bib23","doi-asserted-by":"crossref","first-page":"e00105","DOI":"10.1128\/CMR.00105-19","article-title":"Immunomodulatory strategies in Herpes simplex virus encephalitis","volume":"33","author":"Piret","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virs.2026.01.002_bib24","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1128\/JVI.00517-16","article-title":"A highly efficacious Herpes simplex virus 1 vaccine blocks viral pathogenesis and prevents corneal immunopathology via humoral immunity","volume":"90","author":"Royer","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.01.002_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41385-019-0131-y","article-title":"Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection","volume":"12","author":"Royer","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.virs.2026.01.002_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109890","article-title":"A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains","volume":"9","author":"Stanfield","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.01.002_bib27","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1128\/JVI.00783-12","article-title":"Circumventing antivector immunity by using adenovirus-infected blood cells for repeated application of adenovirus-vectored vaccines: proof of concept in rhesus macaques","volume":"86","author":"Sun","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.01.002_bib28","first-page":"e1","article-title":"Left out but not forgotten: should closer attention be paid to coinfection with herpes simplex virus type 1 and HIV? Can","volume":"20","author":"Tan","year":"2009","journal-title":"J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.virs.2026.01.002_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2171233","article-title":"A recombinant mycobacterium smegmatis-based surface display system for developing the T cell-based COVID-19 vaccine","volume":"19","author":"Wen","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virs.2026.01.002_bib30","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/v15061316","article-title":"Enhancement of SARS-CoV-2 N antigen-specific T cell functionality by modulating the autophagy-mediated signal pathway in mice","volume":"15","author":"Wen","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2026.01.002_bib31","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.95964","article-title":"Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques","volume":"13","author":"Wen","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.virs.2026.01.002_bib32","series-title":"Herpes simplex Virus","year":"2024"},{"key":"10.1016\/j.virs.2026.01.002_bib33","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/14760584.2021.1960162","article-title":"Current vaccine approaches and emerging strategies against herpes simplex virus (HSV)","volume":"20","author":"Wijesinghe","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virs.2026.01.002_bib34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","article-title":"A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity","volume":"586","author":"Yang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.01.002_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1195533","article-title":"Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination","volume":"14","author":"Yin","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.01.002_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010366","article-title":"Kynurenine-3-monooxygenase (KMO) broadly inhibits viral infections via triggering NMDAR\/Ca2+ influx and CaMKII\/IRF3-mediated IFN-\u03b2 production","volume":"18","author":"Zhao","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.01.002_bib37","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1080\/21505594.2021.1982373","article-title":"Pathogenesis and virulence of herpes simplex virus","volume":"12","author":"Zhu","year":"2021","journal-title":"Virulence"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:41:05Z","timestamp":1778834465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X26000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1995820X26000088"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2026.01.002","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic evaluation of HSV-1 \u039434.5\u039447 as a dual-function platform for attenuated HSV-1 vaccine and heterologous antigen delivery","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}